Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-5-9
|
pubmed:abstractText |
A multicenter, randomized, double-masked, parallel-group study compared the long-term efficacy and safety of lodoxamide 0.1% ophthalmic solution and placebo in 118 patients with vernal keratoconjunctivitis. The test drugs were instilled four times daily for 90 days. Lodoxamide 0.1% ophthalmic solution was significantly (P < .05) more effective than placebo in lowering severity scores for epithelial disease and corneal staining, evidence of the superior efficacy of lodoxamide 0.1% ophthalmic solution in reversing the corneal complications commonly associated with moderate to severe vernal keratoconjunctivitis. Additionally, lodoxamide 0.1% ophthalmic solution ameliorated the other key signs of vernal keratoconjunctivitis, including upper tarsal papillae, limbal signs (papillae, hyperemia, and Trantas' dots), and conjunctival discharge. The between-group differences in the relief of symptoms (itching, tearing, and photophobia) were clinically significant but not always statistically significant. Treatment-related adverse events were reported with similar frequency in both treatment groups, and none were serious.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0002-9394
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
488-97
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8154531-Adolescent,
pubmed-meshheading:8154531-Adult,
pubmed-meshheading:8154531-Aged,
pubmed-meshheading:8154531-Analysis of Variance,
pubmed-meshheading:8154531-Child,
pubmed-meshheading:8154531-Child, Preschool,
pubmed-meshheading:8154531-Conjunctivitis, Allergic,
pubmed-meshheading:8154531-Corneal Diseases,
pubmed-meshheading:8154531-Double-Blind Method,
pubmed-meshheading:8154531-Female,
pubmed-meshheading:8154531-Follow-Up Studies,
pubmed-meshheading:8154531-Humans,
pubmed-meshheading:8154531-Male,
pubmed-meshheading:8154531-Middle Aged,
pubmed-meshheading:8154531-Ophthalmic Solutions,
pubmed-meshheading:8154531-Oxamic Acid
|
pubmed:year |
1994
|
pubmed:articleTitle |
Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
|
pubmed:affiliation |
University of Puerto Rico School of Medicine, Rio Piedras.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|